Similar medications and substitutes for SUTIMLIMAB-JOME
In short: Enjaymo (SUTIMLIMAB-JOME) belongs to the Classical Complement Pathway Inhibitor class. The medications listed below either share that mechanism of action or have been clinically validated as substitutes when Enjaymo is unsuitable due to side effects, cost, availability, or contraindications.
No alternatives are listed for Enjaymo in our database yet. Browse the full medicine index or consult your pharmacist for substitution advice.